# Oncology Ventures Fund I-A LP — Form D

Oncology Ventures Fund I-A LP of NEW YORK, NY, a pooled investment fund, filed a Form D exempt-offering notice with the SEC on 2024-05-14. $5.0M was reported sold. Industry: Pooled Investment Fund.

## Offering

- Filed: 2024-05-14
- Form: D
- Accession: 0002022892-24-000001
- Industry: Pooled Investment Fund
- Exemptions: 06b, 3C, 3C.1
- Amount sold: $5.0M
- Minimum investment: $10K
- Investors: 37
- Date of first sale: 2024-04-30
- Security types: fund interests
- Revenue range: Decline to Disclose
- SEC file number: 021-513253

## Issuer

- Name: Oncology Ventures Fund I-A LP
- CIK: 0002022892
- Entity type: Limited Partnership
- Jurisdiction: DELAWARE
- Incorporated: 2024
- Address: 160 EAST 38TH STREET, NEW YORK, NY, 10002
- Phone: 5168512311

## Officers, directors & promoters (3)

| Name | Role | Location |
| --- | --- | --- |
| Ben Freeberg | Executive Officer | Boca Raton, FL |
| N/A Oncology Ventures GP I LLC | Executive Officer | New York, NY |
| N/A Oncology Ventures LLC | Executive Officer | New York, NY |

## More

- [CIK 2022892 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=2022892&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0002022892-24-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.